CircSAMD11 facilitates progression of cervical cancer via regulating miR‐503/SOX4 axis through Wnt/β‐catenin pathway. (12th October 2021)

• Record Type: Journal Article
• Authors: Pan, Qiwen; Meng, Xia; Li, Jianxiang; Qin, Xiaoni; Chen, Huifeng; Li, Yueqing
• Is Part Of: Clinical and experimental pharmacology and physiology. Volume 49:Number 1(2022)
• Page Start: 175
• Page End: 187
• Publication Date: 2021-10-12
• Subjects: cervical cancer -- circSAMD11 -- miR‐503 -- SOX4 -- Wnt/β‐catenin pathway; Clinical pharmacology -- Periodicals; Pharmacology, Experimental -- Periodicals; Physiology, Experimental -- Periodicals; Physiology, Pathological -- Periodicals; 615.1
• DOI: 10.1111/1440-1681.13593
• Languages: English
• ISSNs: 0305-1870

Abstract

Abstract: Cervical cancer (CC) is a common gynaecological malignant tumour with a high mortality rate. Circular RNAs (circRNAs) play a critical role in tumour occurrence and development. This study aimed to investigate the function and molecular basis of hsa_circ_0009189 (circSAMD11) in CC development. RNA levels were determined by qRT‐PCR, and protein expression was measured by western blot. Cell proliferation, migration, invasion and apoptosis were detected by Cell Counting Kit‐8 (CCK‐8), colony formation, Transwell and flow cytometry assays. The relationship between miR‐503 and circSAMD11/SOX4 was validated via dual‐luciferase reporter assay, RIP or RNA pull‐down assay. Xenograft assay was conducted to test tumour growth in vivo . CircSAMD11 and SOX4 levels were elevated, while miR‐503 level was reduced in CC tissues and cells. Knockdown of circSAMD11 suppressed CC cell proliferation, migration and invasion and accelerated apoptosis. CircSAMD11 was localised in cytoplasm and directly targeted miR‐503. Also, circSAMD11 sponged miR‐503 to modulate SOX4 expression. Additionally, circSAMD11 regulated CC progression via absorbing miR‐503 or modulating SOX4. Besides, depletion of circSAMD11 hindered tumorigenesis in vivo . CircSAMD11 contributed to CC progression by regulating miR‐503/SOX4 signalling and activating Wnt/β‐catenin pathway, which provides a promising therapeutic target for cervical cancer.